CIK 0001770787 · Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 455614458
- Phone
- (925) 401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-26 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −492 | $64.75 | $32K | 1,075,349 |
| 2026-08-24 | Saxonov Serge Chief Executive Officer | Sale | −18,545 | $63.02 | $1.2M | 1,085,835 |
| 2026-08-24 | Taich Adam Chief Financial Officer | Sale | −17,166 | $63.02 | $1.1M | 362,732 |
| 2026-08-24 | Hindson Benjamin J. See Remarks | Sale | −13,818 | $63.02 | $871K | 488,182 |
| 2026-08-24 | SULIMAN SHEHNAAZ Director | Sale 10b5-1 | −561 | $62.73 | $35K | 31,161 |
| 2026-08-24 | SULIMAN SHEHNAAZ Director | Sale 10b5-1 | −1,646 | $63.97 | $105K | 29,515 |
| 2026-08-20 | Saxonov Serge Chief Executive Officer | Gift | −4,000 | 1,104,380 | ||
| 2026-08-14 | Teichmann Sarah A. Director | Sale 10b5-1 | −2,273 | $57.15 | $130K | 28,058 |
| 2026-08-13 | Teichmann Sarah A. Director | Sale 10b5-1 | −5,278 | $57.29 | $302K | 30,331 |
| 2026-08-11 | STUELPNAGEL JOHN R Director | Sale | −17,000 | $57.58 | $979K | 351,436 |
| 2026-08-11 | STUELPNAGEL JOHN R Director | Sale | −3,000 | $58.73 | $176K | 348,436 |
| 2026-06-22 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −8,527 | $33.29 | $284K | 1,129,853 |
| 2026-06-22 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −9,991 | $34.28 | $343K | 1,119,862 |
| 2026-06-22 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −9,821 | $35.32 | $347K | 1,110,041 |
| 2026-06-22 | Saxonov Serge Chief Executive Officer | Sale 10b5-1 | −1,661 | $36.16 | $60K | 1,108,380 |
| 2026-06-16 | SULIMAN SHEHNAAZ Director | Sale 10b5-1 | −5,359 | $32.59 | $175K | 32,086 |
| 2026-06-16 | SULIMAN SHEHNAAZ Director | Sale 10b5-1 | −364 | $33.27 | $12K | 31,722 |
| 2026-06-04 | Teichmann Sarah A. Director | Grant or award | +8,829 | 35,609 | ||
| 2026-06-04 | SULIMAN SHEHNAAZ Director | Grant or award | +8,829 | 37,445 | ||
| 2026-06-04 | STUELPNAGEL JOHN R Director | Grant or award | +8,829 | 368,436 |
Page 2 of 8 · 142 trades